• 2 Citations
  • 1 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberto Cauda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
HIV Medicine & Life Sciences
Enterobacteriaceae Infections Medicine & Life Sciences
Affective Symptoms Medicine & Life Sciences
Lamivudine Medicine & Life Sciences
Calcitonin Medicine & Life Sciences
Coinfection Medicine & Life Sciences
Alcohol Drinking Medicine & Life Sciences
Intensive Care Units Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2019 2019

  • 2 Citations
  • 1 h-Index
  • 6 Article

Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population

Ciccarelli, N., Baldonero, E., Milanini, B., Fabbiani, M., Cauda, R., Di Giambenedetto, S. & Silveri, M. C., Sep 1 2019, In : Le infezioni in medicina. 27, 3, p. 274-282 9 p.

Research output: Contribution to journalArticle

Affective Symptoms
Cardiovascular Diseases
Cognitive Dysfunction

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

ICONA Foundation Study group, Oct 15 2019, In : BMC Public Health. 19, 1, p. 1-13 13 p., 1291.

Research output: Contribution to journalArticle

Open Access
Alcohol Drinking
Liver Diseases

Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure

Borghetti, A., Moschese, D., Cingolani, A., Baldin, G., Speziale, D., Ciccullo, A., Lombardi, F., Emiliozzi, A., Belmonti, S., Antinori, A., Cauda, R. & Di Giambenedetto, S., Jun 25 2019, In : HIV Medicine. p. 1-4 4 p.

Research output: Contribution to journalArticle


Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients

Lombardi, F., Belmonti, S., Borghetti, A., Ciccullo, A., Baldin, G., Cauda, R., Fabbiani, M. & Di Giambenedetto, S., May 4 2019, In : HIV Research and Clinical Practice. 20, 3, p. 92-98 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections

Tacconelli, E., Cataldo, M. A., Mutters, N. T., Carrara, E., Bartoloni, A., Raglio, A., Cauda, R., Mantengoli, E., Luzzaro, F., Pan, A., Beccara, L. A., Pecile, P., Tinelli, M. & Rossolini, G. M., Apr 12 2019, In : International Journal of Antimicrobial Agents. p. 1-6

Research output: Contribution to journalArticle

Enterobacteriaceae Infections
Anti-Bacterial Agents
Cross Infection